Predictors of survival in autoimmune liver disease overlap syndromes.

Another study presented MELD approaching significance as a predictor of impaired overall survival in AILDOS patients ( P = 0.05), but the study was limited by a small sample size of five patients in the entire AILDOS cohort, whilst the current study has twenty two patients[ 28 ].

also in 483 other papers